Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-19

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA has approved Lupin Pharmaceuticals' supplemental application for Losartan Potassium, a generic product, via ANDA indicating an additional approved aspect of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)